{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:05:26Z","timestamp":1793142326531,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.genhosppsych.2024.09.005","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T12:23:45Z","timestamp":1726057425000},"page":"60-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["N-methyl-d-aspartate (NMDA) receptor antagonists for treatment of catatonia in adults: Narrative review"],"prefix":"10.1016","volume":"91","author":[{"given":"Jeong Hoo","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.genhosppsych.2024.09.005_bb0005","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2190\/X0FF-VU7G-QQP7-L5V7","article-title":"Somatic treatment of catatonia","volume":"25","author":"Hawkins","year":"1995","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.genhosppsych.2024.09.005_bb0010","series-title":"Evidence-based Consensus Guidelines for the Management of Catatonia: Recommendations from the British Association for Psychopharmacology [Internet]","year":"2024"},{"key":"10.1016\/j.genhosppsych.2024.09.005_bb0015","first-page":"181","article-title":"A clinical review of the treatment of catatonia","volume":"5","author":"Sienaert","year":"2014","journal-title":"Front Psychol"},{"key":"10.1016\/j.genhosppsych.2024.09.005_bb0020","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2147\/NDT.S231573","article-title":"Electroconvulsive therapy for patients with catatonia: current perspectives","volume":"16","author":"Lloyd","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"11","key":"10.1016\/j.genhosppsych.2024.09.005_bb0025","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/CCM.0000000000002642","article-title":"Delirium and catatonia in critically ill patients: the delirium and catatonia prospective cohort investigation*","volume":"45","author":"Wilson","year":"2017","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2024.09.005_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/JCP.0000000000001621","article-title":"Catatonia and delirium: assessment of comorbidity, prevalence, and therapeutic response in medically ill inpatients from a university hospital","volume":"43","author":"Appiani","year":"2023","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"10.1016\/j.genhosppsych.2024.09.005_bb0035","article-title":"Delirium with catatonic features","volume":"26","author":"Francis","year":"2009","journal-title":"Psychiatr Times"},{"issue":"8","key":"10.1016\/j.genhosppsych.2024.09.005_bb0040","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/pcn.12168","article-title":"Do patients of delirium have catatonic features? An exploratory study","volume":"68","author":"Grover","year":"2014","journal-title":"Psychiatry Clin Neurosci"},{"issue":"6","key":"10.1016\/j.genhosppsych.2024.09.005_bb0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.genhosppsych.2015.06.011","article-title":"Catatonia vis-\u00e0-vis delirium: the significance of recognizing catatonia in altered mental status","volume":"37","author":"Oldham","year":"2015","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"10.1016\/j.genhosppsych.2024.09.005_bb0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/schbul\/sbp141","article-title":"Catatonia and its treatment","volume":"36","author":"Rosebush","year":"2010","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.genhosppsych.2024.09.005_bb0055","series-title":"Lorazepam Is an Independent Risk Factor for Transitioning to Delirium in Intensive Care Unit Patients","volume":"vol. 104(1)","author":"Pandharipande","year":"2006"},{"key":"10.1016\/j.genhosppsych.2024.09.005_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2017.06.011","article-title":"Alternative treatment strategies for catatonia: a systematic review","volume":"48","author":"Beach","year":"2017","journal-title":"Gen Hosp Psychiatry"},{"issue":"6","key":"10.1016\/j.genhosppsych.2024.09.005_bb0065","first-page":"281","article-title":"Hero or antagonist: a case series on the tolerability of Memantine as salvage therapy for catatonia from anti-NMDA receptor encephalitis","volume":"31","author":"Wang","year":"2023","journal-title":"Harv Rev Psychiatry"},{"key":"10.1016\/j.genhosppsych.2024.09.005_bb0070","series-title":"Neuropsychiatry of Catatonia: Clinical Implications","first-page":"36","author":"Scott Beach","year":"2019"},{"issue":"5","key":"10.1016\/j.genhosppsych.2024.09.005_bb0080","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1017\/S0140525X02000109","article-title":"What catatonia can tell us about \u201ctop-down modulation\u201d: a neuropsychiatric hypothesis","volume":"25","author":"Northoff","year":"2002","journal-title":"Behav Brain Sci"},{"issue":"2","key":"10.1016\/j.genhosppsych.2024.09.005_bb0085","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/WNF.0b013e318246ad34","article-title":"Treatment of catatonia with amantadine","volume":"35","author":"Hervey","year":"2012","journal-title":"Clin Neuropharmacol"},{"issue":"8","key":"10.1016\/j.genhosppsych.2024.09.005_bb0090","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.bcp.2004.07.034","article-title":"The GABA-glutamate connection in schizophrenia: which is the proximate cause?","volume":"68","author":"Coyle","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"43","key":"10.1016\/j.genhosppsych.2024.09.005_bb0095","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J Neurosci"},{"issue":"12","key":"10.1016\/j.genhosppsych.2024.09.005_bb0100","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00702-002-0762-z","article-title":"Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology","volume":"109","author":"Northoff","year":"2002","journal-title":"J Neural Transm"},{"issue":"11","key":"10.1016\/j.genhosppsych.2024.09.005_bb0105","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.1992.03490110111047","article-title":"The journal of neuropsychiatry and clinical neurosciences","volume":"268","author":"Bowden","year":"1992","journal-title":"JAMA J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.genhosppsych.2024.09.005_bb0110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1176\/jnp.2007.19.4.406","article-title":"Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes","volume":"19","author":"Carroll","year":"2007","journal-title":"J Neuropsychiatr Clin Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.genhosppsych.2024.09.005_bb0115","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.schres.2015.07.029","article-title":"NMDA receptor blockade and catatonia: a complex relationship","volume":"168","author":"Inta","year":"2015","journal-title":"Schizophr Res"},{"issue":"2","key":"10.1016\/j.genhosppsych.2024.09.005_bb0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/10401230600614710","article-title":"Amantadine and memantine in catatonic schizophrenia","volume":"18","author":"Carroll","year":"2006","journal-title":"Ann Clin Psychiatry Off J Am Acad Clin Psychiatr"},{"issue":"6","key":"10.1016\/j.genhosppsych.2024.09.005_bb0130","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1176\/appi.psy.48.6.534","article-title":"Treatment of catatonia with olanzapine and amantadine","volume":"48","author":"Babington","year":"2007","journal-title":"Psychosomatics"},{"issue":"9","key":"10.1016\/j.genhosppsych.2024.09.005_bb0135","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1089\/cap.2015.0064","article-title":"Resistant catatonia in a high-functioning autism Spectrum disorder patient successfully treated with amantadine","volume":"25","author":"Ellul","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2024.09.005_bb0140","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1176\/appi.neuropsych.13010007","article-title":"Successful treatment of catatonia in a young man with Schizophrenia and progressive diffuse cerebral atrophy","volume":"26","author":"Ene-Stroescu","year":"2014","journal-title":"J Neuropsychiatr Clin Neurosci"},{"issue":"4","key":"10.1016\/j.genhosppsych.2024.09.005_bb0145","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/JCP.0b013e31825ebf6e","article-title":"Short-term treatment of catatonia with amantadine in Schizophrenia and schizoaffective disorder","volume":"32","author":"De Lucena","year":"2012","journal-title":"J Clin Psychopharmacol"},{"issue":"04","key":"10.1016\/j.genhosppsych.2024.09.005_bb0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0029-1242821","article-title":"Improvement of mutism in a catatonic Schizophrenia case by add-on treatment with amantadine","volume":"43","author":"Muneoka","year":"2010","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.genhosppsych.2024.09.005_bb0155","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/jnnp.62.4.404","article-title":"Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine","volume":"62","author":"Northoff","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.genhosppsych.2024.09.005_bb0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1176\/appi.neuropsych.15090218","article-title":"Catatonia in neurologic and psychiatric patients at a tertiary neurological center","volume":"28","author":"Espinola-Nadurille","year":"2016","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"10.1016\/j.genhosppsych.2024.09.005_bb0165","first-page":"2011","article-title":"Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery","author":"Mukai","year":"2011","journal-title":"Case Rep Dermatol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2024.09.005_bb0170","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/01.pra.0000400268.60537.5e","article-title":"Memantine and catatonia: a case report and literature review","volume":"17","author":"Obregon","year":"2011","journal-title":"J Psychiatr Pract"},{"issue":"1","key":"10.1016\/j.genhosppsych.2024.09.005_bb0175","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/08897077.2015.1052869","article-title":"Catatonia and cannabis withdrawal: a case report","volume":"37","author":"Caudron","year":"2016","journal-title":"Subst Abus"},{"issue":"2","key":"10.1016\/j.genhosppsych.2024.09.005_bb0180","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1213\/ANE.0000000000001271","article-title":"The association between preoperative frailty and postoperative delirium after cardiac surgery","volume":"123","author":"Brown","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1016\/j.genhosppsych.2024.09.005_bb0185","series-title":"Catatonic Schizophrenia and the Use of Memantine [Internet]","year":"2024"},{"key":"10.1016\/j.genhosppsych.2024.09.005_bb0190","article-title":"Memantine in major depression with catatonic features","year":"2024","journal-title":"J Neuropsych Clin Neurosci"},{"issue":"3","key":"10.1016\/j.genhosppsych.2024.09.005_bb0195","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1176\/appi.ajp.162.3.626","volume":"162","author":"Memantine","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2024.09.005_bb0200","series-title":"Three Patients With Mood Disorders Showing Catatonia and Frontotemporal Lobes Atrophy [Internet]","year":"2024"},{"issue":"11","key":"10.1016\/j.genhosppsych.2024.09.005_bb0205","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_696_23","article-title":"Memantine-responsive catatonia secondary to tuberculosis, neurocysticercosis, and pneumococcal pneumonia: a case series","volume":"65","author":"Bhattacharjee","year":"2023","journal-title":"Indian J Psychiatry"},{"issue":"6","key":"10.1016\/j.genhosppsych.2024.09.005_bb0210","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.psym.2016.08.001","article-title":"Catatonia delirium: 3 cases treated with Memantine","volume":"57","author":"Roy","year":"2016","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1016\/j.genhosppsych.2024.09.005_bb0215","article-title":"Effective use of memantine for catatonia in major depressive disorder after failure of electroconvulsive therapy: a case report","volume":"2","author":"Tanifuji","year":"2023","journal-title":"Psychiatry Clin Neurosci Rep"},{"issue":"6","key":"10.1016\/j.genhosppsych.2024.09.005_bb0220","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaclp.2022.07.003","article-title":"Electroconvulsive therapy-resistant catatonia: case report and literature review","volume":"63","author":"Hasoglu","year":"2022","journal-title":"J Acad Consult-Liaison Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2024.09.005_bb0225","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1176\/appi.neuropsych.20220206","article-title":"Adjunctive memantine for catatonia due to anti-NMDA receptor encephalitis","volume":"36","author":"Kim","year":"2024","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"10.1016\/j.genhosppsych.2024.09.005_bb0230","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neubiorev.2014.08.017","article-title":"The role of NMDA receptors in the pathophysiology and treatment of mood disorders","volume":"47","author":"Ghasemi","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"10.1016\/j.genhosppsych.2024.09.005_bb0235","article-title":"Ketamine for acute catatonia: A case report","volume":"20","author":"Kobayashi","year":"2021","journal-title":"Curr Psychiatr Ther"},{"key":"10.1016\/j.genhosppsych.2024.09.005_bb0240","article-title":"Ketamine as an alternative to ECT in catatonia in elderly women with bipolar disorder: a case report","volume":"14","author":"Sarma","year":"2023","journal-title":"Front Psychol"},{"issue":"5","key":"10.1016\/j.genhosppsych.2024.09.005_bb0245","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jemermed.2019.12.030","article-title":"Catatonia-like syndrome treated with low-dose ketamine","volume":"58","author":"Iserson","year":"2020","journal-title":"J Emerg Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2024.09.005_bb0250","first-page":"1","article-title":"Electroconvulsive therapy (ECT) with ketamine induction for catatonia in an HIV positive patient","volume":"29","author":"Nel","year":"2023","journal-title":"South Afr J Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.genhosppsych.2024.09.005_bb0255","article-title":"Intranasal Esketamine administration in catatonia: a case report","volume":"66","author":"Romay","year":"2023","journal-title":"Eur Psychiatry"},{"issue":"2","key":"10.1016\/j.genhosppsych.2024.09.005_bb0260","first-page":"138","article-title":"Dextromethorphan\/quinidine withdrawal-emergent catatonia","volume":"28","author":"Turner","year":"2016","journal-title":"Ann Clin Psychiatry Off J Am Acad Clin Psychiatr"},{"key":"10.1016\/j.genhosppsych.2024.09.005_bb0265","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.genhosppsych.2017.10.010","article-title":"NMDA antagonists in the treatment of catatonia: a review of case studies from the last 10years","volume":"51","author":"Theibert","year":"2018","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2024.09.005_bb0270","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pnpbp.2006.08.013","article-title":"Possible antipsychotic effects of minocycline in patients with schizophrenia","volume":"31","author":"Miyaoka","year":"2007","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2024.09.005_bb0275","series-title":"Handbook of Clinical Neurology [Internet]","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-0-444-64196-0.00012-1","article-title":"Chapter 12 - Cingulate-basal ganglia-thalamo-cortical aspects of catatonia and implications for treatment","author":"Fricchione","year":"2019"},{"issue":"3","key":"10.1016\/j.genhosppsych.2024.09.005_bb0280","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Witkin JM, editor","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.genhosppsych.2024.09.005_bb0285","article-title":"The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review","volume":"14","author":"Sepulveda Ramos","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.genhosppsych.2024.09.005_bb0290","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"10.1016\/j.genhosppsych.2024.09.005_bb0295","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/14737175.2019.1640604","article-title":"Esketamine for treatment resistant depression","volume":"19","author":"Swainson","year":"2019","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"10.1016\/j.genhosppsych.2024.09.005_bb0300","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","article-title":"Effects of ketamine in normal and schizophrenic volunteers","volume":"25","author":"Lahti","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.genhosppsych.2024.09.005_bb0305","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4693","article-title":"Association of Ketamine with psychiatric symptoms and Implications for its therapeutic use and for understanding schizophrenia: a systematic review and meta-analysis","volume":"3","author":"Beck","year":"2020","journal-title":"JAMA Netw Open"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834324001944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834324001944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T04:22:06Z","timestamp":1733718126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834324001944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":59,"alternative-id":["S0163834324001944"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2024.09.005","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-methyl-d-aspartate (NMDA) receptor antagonists for treatment of catatonia in adults: Narrative review","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2024.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}